Biotech Startups

NB Health Laboratory develops antibody therapeutics for drug discovery and development to address unmet medical needs in healthcare.

1 investor

NC Biomatrix develops biologic therapies targeting musculoskeletal degeneration, with a lead product (VitaDisc) addressing intervertebral disc degeneration and chronic lower back pain, and ongoing research into osteoarthritis treatments for synovial joints.

1 investor

nData builds GxP-ready software for pharmaceutical and life-science organizations, offering focused applications and a connected digital ecosystem covering R&D, quality control, regulatory, document management and product launch processes. The company, based in Europe, supports customers from solution design through implementation, rollout and long-term operation.

1 investor

Nectero Therapeutics develops therapeutic medical devices with a focus on vascular medicine applications. The company is led by a team with extensive experience in regulatory affairs, product development, and quality assurance for medical device manufacturing.

1 investor

Neion Bio develops a biomanufacturing platform that re-engineers eggs into living bioreactors to produce biological molecules such as monoclonal antibodies, enzymes, fusion proteins, peptides, and cytokines. It serves biopharma partners across biosimilars, biotech, animal health, and reagents, aiming to lower the cost and increase the consistency of biologics production.

1 investor

MyHealthChecked provides personalized health testing infrastructure and wellness management services designed to help individuals understand their personal health priorities and make sustainable lifestyle improvements.

1 investor

NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.

1 investor

1 investor

NEMIS develops diagnostic solutions for rapid, on-site detection of food contamination, supporting quality control teams across the food production value chain. Its technology combines on-site detection, AI-enabled preventive health checks, and hygiene protocols to reduce contamination risks and prevent recalls.

1 investor

Biopharmaceutical company developing cannabis-based therapeutics for unmet medical needs.

1 investor

Neo-Bionica develops neurotechnology devices and systems, leveraging expertise in implantable device design, neural interfaces, and medical device engineering for the neurotech market.

1 investor

Neobiomics develops multi-strain food supplements rooted in academic research, with collaborations across Europe. The company is affiliated with Karolinska Institutet and focuses on bringing innovative, science-based nutritional products to market.

1 investor

Neocrop Technologies is a biotech company that develops new crop varieties through precision genetic breeding, using CRISPR gene editing, non-GMO methods, accelerated growth chambers, and proprietary gene-selection software. It serves seed companies, public and private institutions, and R&D centers in plant science, fruit, and forestry, with projects focused on Chilean and Argentine crop lines.

1 investor

Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.

1 investor

Neopharm is a South Korean cosmetics and skincare company that develops proprietary ingredients and products, including scalp-care shampoos and dermatological skincare items. It is a publicly listed company (ticker: 네오팜) offering consumer beauty and skin health products.

1 investor

Neos Therapeutics was a pharmaceutical company developing and commercializing ADHD treatments, including the branded dissolvable medications Adzenys and Cotempla.

1 investor

Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.

1 investor

NeoVac develops proprietary lipid technology for lipid nanoparticles (LNPs) designed to support mRNA-based therapeutics in vaccines, cancer immunotherapy, and autoimmune disease treatment. The company's lipid platform emphasizes tunable degradability to enhance safety and efficacy profiles.

1 investor

Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease. It focuses on research and innovation for patients with diabetic renal disease.

1 investor

Nephrodi is a biotechnology company developing treatments for kidney conditions, including the rare disease Nephrogenic Diabetes Insipidus (NDI). Its work centers on renal physiology research and translating it toward clinical products.

1 investor

NeraCare develops clinically validated prognostic tests that personalize survival prediction and risk stratification for patients with early-stage melanoma, guiding adjuvant therapy decisions. The company operates as a partnership-driven diagnostics firm supporting clinical studies and collaborations across Europe and the U.S.

1 investor

Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.

1 investor

Phosphatase-focused immunotherapy drug discovery company; acquired by Boehringer-Ingelheim for up to $1.3B in 2024.

1 investor

NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.

1 investor